Annual Lung SPORE Workshop (Abstract Submission): Submission #73

Submission information
Submission Number: 73
Submission ID: 110636
Submission UUID: e75190f5-e7c6-43ad-a0fb-74d830761921

Created: Mon, 03/11/2024 - 15:01
Completed: Mon, 03/11/2024 - 15:01
Changed: Fri, 05/10/2024 - 14:38

Remote IP address: 10.208.24.212
Submitted by: Anonymous
Language: English

Is draft: No
serial: '73'
sid: '110636'
uuid: e75190f5-e7c6-43ad-a0fb-74d830761921
uri: /dctd/lungsporemeeting/abstracts
created: '1710183698'
completed: '1710183718'
changed: '1715366315'
in_draft: '0'
current_page: ''
remote_addr: 10.208.24.212
uid: '0'
langcode: en
webform_id: lung_spore_investigator_abstract
entity_type: node
entity_id: '1171'
locked: '0'
sticky: '0'
notes: ''
data:
  additional_authors_list:
    - affiliation: 'Research Advocacy Network'
      first_name: Elda
      last_name: Railey
  topic_classification:
    - 'Session 1: Oncogene-driven lung cancers and resistance to targeted therapies'
  abstract_review_status: 'Approved to be a Speaker'
  abstract_title: 'Partnering with Patient Research Advocates '
  affiliation_author1: 'Fred Hutch SPORE (patient advocate)'
  affiliation_presenter: 'Fred Hutch SPORE (patient advocate)'
  email: janet.f-d@comcast.net
  first_name: Janet
  first_name_author1: Janet
  last_name: Freeman-Daily
  last_name_author1: Freeman-Daily
  phone: 253-606-2173
  poster_uploaded: ''
  special_characters_included_: '0'
  upload_abstract_1: '44503'
  upload_poster: ''